Answers are grounded in this paper and cite their sources.
mutations. Our results support further optimization of multiplex assays and evaluation of sequential testing strategies for patients without detected driver oncogenes on initial testing.
No takes yet. Share an insight, caveat, or question.
Ishida et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: